Submitted by Anonymous (not verified) on 20 November 2023 - 9:34
Human medicines European public assessment report (EPAR): Briviact (in Italy: Nubriveo), brivaracetam, Epilepsy, Date of authorisation: 13/01/2016, Revision: 22, Status: Authorised
Source: